Home
>
National Drug Code (NDC)
>
Mefenamic acid
Mefenamic acid - 0574-0195-30 - (Mefenamic acid)
Drug Information of Mefenamic acid
| Product NDC: | 0574-0195 |
| Proprietary Name: | Mefenamic acid |
| Non Proprietary Name: | Mefenamic acid |
| Active Ingredient(s): | 250 mg/1 & nbsp; Mefenamic acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mefenamic acid
| Product NDC: | 0574-0195 |
| Labeler Name: | Paddock Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090562 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101010 |
Package Information of Mefenamic acid
| Package NDC: | 0574-0195-30 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (0574-0195-30) |
NDC Information of Mefenamic acid
| NDC Code | 0574-0195-30 |
| Proprietary Name | Mefenamic acid |
| Package Description | 30 CAPSULE in 1 BOTTLE (0574-0195-30) |
| Product NDC | 0574-0195 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mefenamic acid |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20101010 |
| Marketing Category Name | ANDA |
| Labeler Name | Paddock Laboratories, Inc. |
| Substance Name | MEFENAMIC ACID |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
